Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > General > Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications
  • General

Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications

Ophthalmology 360

Key Takeaways

  1. The technique showed 0% recurrence at nearly 1 year of follow-up.
  2. No complications occurred, with reduced operative time and postoperative burden.

A glueless, sutureless pterygium excision technique using a triple-layer dehydrated, decellularized amniotic basement membrane with brief mitomycin-C exposure was associated with 0% recurrence and no reported complications at a mean follow-up of 394 days, according to a study.

The triple-layer dehydrated, decellularized amniotic basement membrane used in this study differs from traditional amniotic membrane tissue (AMT). The decellularization process removes the pro-inflammatory chorion and residual donor cellular debris, reducing immunogenicity while preserving extracellular matrix components such as collagen, fibronectin, and laminin. These structural proteins support anti-inflammatory cytokine and growth factor activity, which may aid epithelial adhesion and migration.

The analysis included 34 eyes from 33 patients who underwent pterygium excision with the dehydrated, triple-layer decellularized basement membrane. Patients reported minimal postoperative discomfort, and operative eyes demonstrated minimal subconjunctival injection. At a mean follow-up of 394 days (range, 174–668 days), no recurrences were observed (0/34 eyes). There were also no cases of pyogenic granuloma, infection, dellen, or corneal melt.

According to the authors, compared with traditional AMT and conjunctival autograft techniques performed with glue or sutures, the described approach reduced operative time, postoperative discomfort, follow-up visits, and topical steroid use, while also lowering costs without compromising outcomes.

Reference

McDonald M. A Retrospective Review of Glueless, Sutureless Pterygium Excision Using Biovance Triple-Layer Decellularized Amniotic Basement Membrane Tissue. Ophthalmol Ther. 2026;15, 771–780 (2026). https://doi.org/10.1007/s40123-026-01311-6.

Share

Related Content

  • Cornea and External Disease

Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient

  • General

Glaucoma may signal complications in intraocular cancers, review suggests

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

  • General

XEN63 Gel Stent shows sustained glaucoma control over 3 years

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon